| Symbol | ENVB |
|---|---|
| Name | ENVERIC BIOSCIENCES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 245 FIRST STREET,RIVERVIEW II,18TH FLOOR, CAMBRIDGE, Massachusetts, 02142, United States |
| Telephone | +1 617 - 444-8400 |
| Fax | — |
| — | |
| Website | https://www.enveric.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000890821 |
| Description | Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Additional info from NASDAQ: |
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Read moreEnveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Read moreEnveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Read moreEnveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Read moreEnveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Read moreEnveric Biosciences Announces Participation in 2026 BIO International Convention
Read moreEnveric Biosciences Announces Participation in 2026 BIO International Convention
Read more(99% Neutral) ENVERIC BIOSCIENCES, INC. (ENVB) Announces Business Combination
Read moreNew Form 424B5 - Enveric Biosciences, Inc. <b>Filed:</b> 2026-06-09 <b>AccNo:</b> 0001493152-26-027975 <b>Size:</b> 18 KB
Read more